SABS

SAB Biotherapeutics Inc

$3.87
0.03 (0.77%) Today
Compare SABS
Market Cap
$298M+119.9%
Revenue (TTM)
$0
Net Income (TTM)
$-108,198,546
EPS (TTM)
-1.42
Shares Out
76.46M
P/E Ratio
22.47
Open
$3.90
Previous Close
$3.90
Day Range
$3.84 – $3.93
52-Week Range
$1.72 – $6.60
Beta
0.55
Volume
172.18K
Avg Volume
832.33K
Analyst Rating
Buy
Exchange
NASDAQ NMS - GLOBAL MARKET

About SABS

Related

LYELvs
RNACvs
NWBOvs
SRZNvs
FHTXvs

News

N/A
Barclays Initiates Coverage On SAB Biotherapeutics with Overweight Rating, Announces Price Target of $13
Benzinga · 1w ago